93 related articles for article (PubMed ID: 30111862)
21. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.
Wilken R; Veena MS; Wang MB; Srivatsan ES
Mol Cancer; 2011 Feb; 10():12. PubMed ID: 21299897
[TBL] [Abstract][Full Text] [Related]
22. Curcumin and analogues against head and neck cancer: From drug delivery to molecular mechanisms.
Zhao C; Zhou X; Cao Z; Ye L; Cao Y; Pan J
Phytomedicine; 2023 Oct; 119():154986. PubMed ID: 37506572
[TBL] [Abstract][Full Text] [Related]
23. Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds.
Vishwakarma V; New J; Kumar D; Snyder V; Arnold L; Nissen E; Hu Q; Cheng N; Miller D; Thomas AR; Shnayder Y; Kakarala K; Tsue TT; Girod DA; Thomas SM
Sci Rep; 2018 Aug; 8(1):12163. PubMed ID: 30111862
[TBL] [Abstract][Full Text] [Related]
24. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways.
Sivanantham B; Sethuraman S; Krishnan UM
ACS Comb Sci; 2016 Jan; 18(1):22-35. PubMed ID: 26505786
[TBL] [Abstract][Full Text] [Related]
25. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S
Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083
[TBL] [Abstract][Full Text] [Related]
26. Antitumor effects of lapatinib (GW572016), a dual inhibitor of EGFR and HER-2, in combination with cisplatin or paclitaxel on head and neck squamous cell carcinoma.
Kondo N; Tsukuda M; Ishiguro Y; Kimura M; Fujita K; Sakakibara A; Takahashi H; Toth G; Matsuda H
Oncol Rep; 2010 Apr; 23(4):957-63. PubMed ID: 20204279
[TBL] [Abstract][Full Text] [Related]
27. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
[TBL] [Abstract][Full Text] [Related]
28. Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment.
Fang WB; Yao M; Brummer G; Acevedo D; Alhakamy N; Berkland C; Cheng N
Oncotarget; 2016 Aug; 7(31):49349-49367. PubMed ID: 27283985
[TBL] [Abstract][Full Text] [Related]
29. The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.
Ledgerwood LG; Kumar D; Eterovic AK; Wick J; Chen K; Zhao H; Tazi L; Manna P; Kerley S; Joshi R; Wang L; Chiosea SI; Garnett JD; Tsue TT; Chien J; Mills GB; Grandis JR; Thomas SM
Oncotarget; 2016 May; 7(19):27185-98. PubMed ID: 27034009
[TBL] [Abstract][Full Text] [Related]
30. Curcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1.
Hu A; Huang JJ; Li RL; Lu ZY; Duan JL; Xu WH; Chen XP; Fan JP
Sci Rep; 2015 Aug; 5():13429. PubMed ID: 26299580
[TBL] [Abstract][Full Text] [Related]
31. Arum Palaestinum with isovanillin, linolenic acid and β-sitosterol inhibits prostate cancer spheroids and reduces the growth rate of prostate tumors in mice.
Cole C; Burgoyne T; Lee A; Stehno-Bittel L; Zaid G
BMC Complement Altern Med; 2015 Aug; 15():264. PubMed ID: 26243305
[TBL] [Abstract][Full Text] [Related]
32. Targeting angiogenesis in head and neck cancer.
Vassilakopoulou M; Psyrri A; Argiris A
Oral Oncol; 2015 May; 51(5):409-15. PubMed ID: 25680863
[TBL] [Abstract][Full Text] [Related]
33. Potential anticancer properties and mechanisms of action of curcumin.
Vallianou NG; Evangelopoulos A; Schizas N; Kazazis C
Anticancer Res; 2015 Feb; 35(2):645-51. PubMed ID: 25667441
[TBL] [Abstract][Full Text] [Related]
34. Prevention of head and neck squamous cell carcinoma: removing the "chemo" from "chemoprevention".
Saba NF; Haigentz M; Vermorken JB; Strojan P; Bossi P; Rinaldo A; Takes RP; Ferlito A
Oral Oncol; 2015 Feb; 51(2):112-8. PubMed ID: 25434586
[TBL] [Abstract][Full Text] [Related]
35. Phenethyl isothiocyanate induces DNA damage-associated G2/M arrest and subsequent apoptosis in oral cancer cells with varying p53 mutations.
Yeh YT; Yeh H; Su SH; Lin JS; Lee KJ; Shyu HW; Chen ZF; Huang SY; Su SJ
Free Radic Biol Med; 2014 Sep; 74():1-13. PubMed ID: 24952138
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
